The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers convenient weekly dosing compared with daily basal insulin injections. Yahoo: New weekly insulin shot could replace daily injections for people with Type 2 diabetes New weekly insulin shot could replace daily injections for people with Type 2 diabetes Ars Technica: Injection of “smart insulin” regulates blood glucose levels for one week